,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.0,Mental disorder,16331210
0,3,22.0,Abdominal distension,16331235
0,6,22.0,Radiotherapy,16331236
1,6,22.0,Haemorrhage,16331236
0,,22.0,Urinary retention,16331316
0,3,22.0,Hip fracture,16331442
0,2,22.0,Febrile neutropenia,16331595
0,6,22.0,Neoplasm progression,16331643
0,4,22.0,Cardiac failure,16331724
1,4,22.0,Multiple organ dysfunction syndrome,16331724
2,4,22.0,Cardiogenic shock,16331724
0,,22.0,Vomiting,16331808
1,,22.0,Abdominal pain,16331808
2,,22.0,Haemoglobin decreased,16331808
3,,22.0,Asthenia,16331808
4,,22.0,Hypotension,16331808
5,,22.0,Therapy cessation,16331808
0,2,22.0,Neurotoxicity,16331858
1,2,22.0,Nail disorder,16331858
2,2,22.0,Pleural effusion,16331858
3,2,22.0,Alopecia,16331858
4,2,22.0,Eye pain,16331858
0,1,22.0,Cerebellar infarction,16331859
1,6,22.0,Vertigo,16331859
2,6,22.0,C-reactive protein increased,16331859
3,6,22.0,Anaemia,16331859
4,6,22.0,Coordination abnormal,16331859
5,1,22.0,Aortic thrombosis,16331859
6,6,22.0,Renal infarct,16331859
0,3,22.0,Ejection fraction decreased,16332042
0,5,22.0,Death,16332059
0,,22.0,Cerebrovascular accident,16332076
0,6,22.0,Acute kidney injury,16332172
1,6,22.0,Myositis,16332172
2,1,22.0,Blood creatine phosphokinase increased,16332172
3,6,22.0,Rash maculo-papular,16332172
0,6,22.1,Nausea,16332202
1,1,22.1,Gingival pain,16332202
2,1,22.1,Stomatitis,16332202
3,6,22.1,Bone marrow failure,16332202
4,6,22.1,Fatigue,16332202
0,5,22.0,Abdominal distension,16332218
0,6,22.0,Syncope,16332225
1,6,22.0,Abdominal pain upper,16332225
2,6,22.0,Depressed level of consciousness,16332225
0,4,22.0,Thrombophlebitis superficial,16332227
1,4,22.0,Pulmonary embolism,16332227
2,4,22.0,Ischaemic stroke,16332227
3,4,22.0,Deep vein thrombosis,16332227
0,1,22.0,Headache,16332240
1,6,22.0,Drug ineffective,16332240
2,6,22.0,Malignant neoplasm progression,16332240
3,6,22.0,Prostatic specific antigen increased,16332240
4,1,22.0,Dizziness,16332240
5,1,22.0,Blindness,16332240
6,1,22.0,Confusional state,16332240
7,6,22.0,Intentional dose omission,16332240
0,2,22.0,Musculoskeletal pain,16332241
1,6,22.0,Pain,16332241
2,2,22.0,Fatigue,16332241
3,1,22.0,Haemoglobin decreased,16332241
0,1,22.0,Gait disturbance,16332246
1,3,22.0,Arthralgia,16332246
2,3,22.0,Hemiparesis,16332246
3,3,22.0,Joint stiffness,16332246
0,6,22.0,Laboratory test abnormal,16332297
0,1,22.0,Anaphylactic reaction,16332325
0,3,22.0,Dizziness,16332343
1,3,22.0,Bone pain,16332343
0,6,22.1,Asthenia,16332348
1,3,22.1,Fatigue,16332348
2,6,22.1,White blood cell count decreased,16332348
3,6,22.1,Vomiting,16332348
0,3,22.0,Dysphonia,16332366
1,6,22.0,Sinus disorder,16332366
2,6,22.0,Fatigue,16332366
3,6,22.0,Vision blurred,16332366
4,6,22.0,Aphonia,16332366
0,6,22.1,Affective disorder,16332369
1,6,22.1,Memory impairment,16332369
2,6,22.1,Neoplasm progression,16332369
3,6,22.1,Dizziness,16332369
4,6,22.1,Fatigue,16332369
0,6,22.0,Thyroid mass,16332443
0,6,22.0,Depression,16332454
0,6,22.0,Memory impairment,16332470
1,6,22.0,Product dose omission,16332470
2,6,22.0,Tooth disorder,16332470
0,1,22.0,Application site pruritus,16332496
1,6,22.0,Application site dryness,16332496
2,1,22.0,Application site irritation,16332496
3,1,22.0,Application site erythema,16332496
4,1,22.0,Wrong technique in product usage process,16332496
5,6,22.0,Product adhesion issue,16332496
0,1,22.0,Erythema,16332523
0,6,22.1,Weight decreased,16332633
1,6,22.1,Urine odour abnormal,16332633
2,3,22.1,Bone pain,16332633
3,6,22.1,Dysgeusia,16332633
4,6,22.1,Nausea,16332633
5,6,22.1,White blood cell count decreased,16332633
6,6,22.1,Body temperature increased,16332633
7,6,22.1,Fatigue,16332633
8,6,22.1,Vomiting,16332633
9,6,22.1,Neoplasm progression,16332633
10,6,22.1,Abdominal pain,16332633
0,6,22.0,Chest discomfort,16332640
1,6,22.0,Fatigue,16332640
0,6,22.0,Pain,16332645
0,6,22.0,Product use issue,16332646
1,6,22.0,Off label use,16332646
0,6,22.0,Fatigue,16332655
0,6,22.0,Neoplasm progression,16332656
1,6,22.0,Fatigue,16332656
2,6,22.0,Neuropathy peripheral,16332656
0,6,22.1,Infected skin ulcer,16332658
1,6,22.1,Constipation,16332658
0,3,22.0,Alopecia,16332664
1,6,22.0,Diverticulum,16332664
2,3,22.0,Fatigue,16332664
3,6,22.0,Nausea,16332664
0,3,22.0,Hair disorder,16332695
1,3,22.0,Alopecia,16332695
2,3,22.0,Madarosis,16332695
3,3,22.0,Hair texture abnormal,16332695
4,3,22.0,Hair colour changes,16332695
0,3,22.0,Fatigue,16332760
1,3,22.0,Alopecia,16332760
2,3,22.0,Diarrhoea,16332760
0,6,22.0,Neutrophil count decreased,16332872
0,3,22.1,Hair disorder,16332877
1,3,22.1,Hair colour changes,16332877
2,3,22.1,Alopecia,16332877
3,3,22.1,Madarosis,16332877
4,3,22.1,Hair texture abnormal,16332877
0,6,22.1,Pruritus,16332883
1,6,22.1,Alopecia,16332883
0,1,22.1,Nausea,16332886
1,6,22.1,Alopecia,16332886
2,6,22.1,Anxiety,16332886
0,6,22.0,Chronic obstructive pulmonary disease,16332899
1,6,22.0,Nausea,16332899
2,6,22.0,Vomiting,16332899
3,6,22.0,Osteopenia,16332899
4,6,22.0,Neoplasm progression,16332899
5,6,22.0,Gout,16332899
6,6,22.0,Neutropenia,16332899
0,2,22.0,Blood count abnormal,16332900
1,6,22.0,Affective disorder,16332900
2,6,22.0,Pain,16332900
3,6,22.0,Anger,16332900
0,1,22.0,Aspartate aminotransferase increased,16332901
1,1,22.0,Alanine aminotransferase increased,16332901
2,1,22.0,Interstitial lung disease,16332901
0,3,22.1,Hair texture abnormal,16332904
1,3,22.1,Hair colour changes,16332904
2,3,22.1,Hair disorder,16332904
3,3,22.1,Alopecia,16332904
0,1,22.1,Fatigue,16332905
1,6,22.1,Confusional state,16332905
2,1,22.1,Loss of consciousness,16332905
3,6,22.1,Influenza,16332905
4,1,22.1,Pruritus,16332905
5,1,22.1,Rash,16332905
6,6,22.1,Nasopharyngitis,16332905
0,3,22.0,Hair colour changes,16332906
1,3,22.0,Alopecia,16332906
2,3,22.0,Hair texture abnormal,16332906
3,3,22.0,Hair disorder,16332906
0,6,22.0,Fatigue,16332907
1,6,22.0,White blood cell count decreased,16332907
2,6,22.0,Musculoskeletal chest pain,16332907
0,3,22.0,Hair disorder,16332908
1,3,22.0,Hair colour changes,16332908
2,3,22.0,Madarosis,16332908
3,3,22.0,Hair texture abnormal,16332908
4,3,22.0,Alopecia,16332908
0,6,22.1,Venoocclusive disease,16332923
1,6,22.1,Chronic hepatic failure,16332923
2,6,22.1,Laboratory test abnormal,16332923
3,6,22.1,Clostridium difficile infection,16332923
4,6,22.1,Constipation,16332923
5,6,22.1,Feeling abnormal,16332923
6,6,22.1,Nausea,16332923
7,6,22.1,Ascites,16332923
8,6,22.1,Oedema peripheral,16332923
9,6,22.1,Transaminases increased,16332923
10,6,22.1,Asthenia,16332923
11,6,22.1,Hepatic encephalopathy,16332923
12,6,22.1,Confusional state,16332923
13,6,22.1,Vomiting,16332923
14,5,22.1,Death,16332923
15,1,22.1,Haemoptysis,16332923
16,6,22.1,Acute kidney injury,16332923
17,6,22.1,Decreased appetite,16332923
0,6,22.0,Aortic aneurysm,16332942
1,6,22.0,Off label use,16332942
0,5,22.0,Death,16332943
1,6,22.0,Off label use,16332943
0,5,22.0,Death,16332948
1,6,22.0,Haematemesis,16332948
0,5,22.0,Malignant neoplasm progression,16332950
1,3,22.0,Altered state of consciousness,16332950
2,6,22.0,Neutrophil count decreased,16332950
3,3,22.0,Liver disorder,16332950
0,6,22.0,Pancytopenia,16332967
0,1,22.0,Platelet count decreased,16333103
0,6,22.0,Spinal stenosis,16333124
1,6,22.0,Spinal fracture,16333124
2,6,22.0,Constipation,16333124
3,6,22.0,Fatigue,16333124
4,6,22.0,Nausea,16333124
5,6,22.0,Gastrooesophageal reflux disease,16333124
0,5,22.0,Death,16333144
1,6,22.0,Myocardial infarction,16333144
2,6,22.0,White blood cell count increased,16333144
0,6,22.0,Deafness,16333163
0,6,22.0,Deafness,16333164
0,3,22.0,Neoplasm progression,16333166
0,6,22.0,Deafness,16333182
0,6,22.0,Neoplasm progression,16333183
0,3,22.0,Pulmonary fibrosis,16333285
1,3,22.0,Condition aggravated,16333285
2,3,22.0,Dyspnoea,16333285
0,6,22.0,Drug ineffective,16333303
1,6,22.0,Insomnia,16333303
2,6,22.0,Hypokalaemia,16333303
3,6,22.0,Product use in unapproved indication,16333303
4,6,22.0,Osteoporosis,16333303
0,6,22.0,Platelet count decreased,16333311
1,6,22.0,Decreased appetite,16333311
2,6,22.0,Anaemia,16333311
3,6,22.0,Chronic kidney disease,16333311
0,1,22.1,Decreased appetite,16333317
1,6,22.1,Hypertension,16333317
2,6,22.1,Neutropenia,16333317
3,6,22.1,Pain in jaw,16333317
4,6,22.1,Diarrhoea,16333317
5,1,22.1,Fatigue,16333317
6,6,22.1,Abdominal pain,16333317
7,6,22.1,Drug ineffective,16333317
8,6,22.1,Clostridium difficile colitis,16333317
0,6,22.1,Hypertension,16333324
1,6,22.1,Diabetes mellitus,16333324
0,6,22.0,Drug resistance,16333331
0,1,22.0,Dyspnoea,16333349
1,1,22.0,Anxiety,16333349
2,1,22.0,Erythema,16333349
0,6,22.0,Lung disorder,16333366
1,6,22.0,Drug hypersensitivity,16333366
2,6,22.0,Cardiac failure congestive,16333366
3,6,22.0,Lymphoedema,16333366
0,6,22.0,Colon cancer,16333397
0,2,22.0,Neuropathy peripheral,16333455
1,1,22.0,Pyrexia,16333455
2,1,22.0,Rash,16333455
0,1,22.0,Acute kidney injury,16333474
0,1,22.1,Decreased appetite,16333505
1,1,22.1,Cholecystitis,16333505
2,2,22.1,Adrenocorticotropic hormone deficiency,16333505
0,6,22.0,Malignant neoplasm progression,16333585
1,6,22.0,Anaemia,16333585
0,3,22.0,Thyroxine free abnormal,16333595
1,3,22.0,Hyperthyroidism,16333595
2,6,22.0,Pulmonary mass,16333595
3,6,22.0,Tachycardia,16333595
4,6,22.0,Disease progression,16333595
5,6,22.0,Neuralgia,16333595
6,1,22.0,Hypokalaemia,16333595
0,1,22.0,Haemolysis,16333598
1,1,22.0,Thrombotic microangiopathy,16333598
2,3,22.0,Systemic mycosis,16333598
3,2,22.0,Hypertension,16333598
0,3,22.0,Overdose,16333730
1,1,22.0,Drug ineffective,16333730
2,3,22.0,Breast cancer female,16333730
3,3,22.0,Breast cancer recurrent,16333730
0,3,22.0,Muscle atrophy,16333756
1,3,22.0,Respiratory rate increased,16333756
2,3,22.0,Weight decreased,16333756
3,3,22.0,Fatigue,16333756
4,3,22.0,Pain in extremity,16333756
5,3,22.0,Pallor,16333756
6,3,22.0,Gait inability,16333756
0,6,22.0,Breast cancer,16333764
1,6,22.0,Osteopenia,16333764
2,6,22.0,Device malfunction,16333764
3,6,22.0,Circumstance or information capable of leading to medication error,16333764
0,5,22.0,Death,16333776
0,1,22.0,Lung disorder,16333821
1,1,22.0,Pyrexia,16333821
2,1,22.0,Pathological fracture,16333821
3,1,22.0,Hepatic function abnormal,16333821
4,2,22.0,Pleural effusion,16333821
0,3,22.0,Skin exfoliation,16333847
1,,22.0,Malaise,16333847
2,,22.0,Inappropriate schedule of product administration,16333847
3,,22.0,Pain,16333847
4,,22.0,Pain in extremity,16333847
5,,22.0,Glossodynia,16333847
6,,22.0,Incorrect dose administered,16333847
7,,22.0,Oral pain,16333847
8,3,22.0,Diarrhoea,16333847
9,,22.0,Incorrect route of product administration,16333847
10,3,22.0,Neuropathy peripheral,16333847
11,3,22.0,Skin fissures,16333847
0,6,22.0,Neutrophil count decreased,16333853
1,6,22.0,Blood alkaline phosphatase increased,16333853
2,6,22.0,Hepatic function abnormal,16333853
3,6,22.0,Hypertension,16333853
0,2,22.0,Neutropenia,16333858
1,2,22.0,Leukopenia,16333858
0,6,22.0,Pollakiuria,16333882
1,6,22.0,Cholangitis infective,16333882
2,6,22.0,Hypokalaemia,16333882
3,6,22.0,Micturition urgency,16333882
4,6,22.0,Disseminated intravascular coagulation,16333882
5,6,22.0,Bile duct stone,16333882
0,6,22.0,Adverse event,16333883
0,6,22.0,Hypokalaemia,16333884
1,6,22.0,Sepsis,16333884
2,6,22.0,Pollakiuria,16333884
3,6,22.0,Pyelonephritis acute,16333884
4,6,22.0,Hyperbilirubinaemia,16333884
5,6,22.0,Ureterolithiasis,16333884
6,6,22.0,Nephrolithiasis,16333884
7,6,22.0,Micturition urgency,16333884
0,5,22.0,Sepsis,16333885
1,6,22.0,Cardiac failure,16333885
2,5,22.0,Prostate cancer metastatic,16333885
3,6,22.0,Pneumonia,16333885
4,6,22.0,Hypoglycaemia,16333885
5,6,22.0,Hypoproteinaemia,16333885
6,6,22.0,Urinary tract infection,16333885
0,6,22.0,Drug intolerance,16333886
1,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16333886
0,6,22.0,Stomatitis,16333888
1,1,22.0,Drug intolerance,16333888
2,1,22.0,Blister,16333888
0,2,22.0,Interstitial lung disease,16333891
1,6,22.0,Inappropriate schedule of product administration,16333891
2,6,22.0,Malaise,16333891
3,2,22.0,Anaemia,16333891
0,5,22.0,Loss of consciousness,16333904
1,5,22.0,Dependence on oxygen therapy,16333904
2,5,22.0,Cardiac arrest,16333904
3,5,22.0,Dyspnoea,16333904
4,5,22.0,Pneumonia,16333904
5,5,22.0,Pulmonary function test decreased,16333904
0,5,22.0,Death,16333988
0,6,22.0,Malignant neoplasm progression,16334015
0,6,22.0,Malignant neoplasm progression,16334016
0,6,22.0,Diarrhoea,16334027
1,6,22.0,Dizziness,16334027
2,6,22.0,Dry skin,16334027
3,6,22.0,Decreased appetite,16334027
0,1,22.0,Glomerular filtration rate decreased,16334049
0,,22.0,Blood bilirubin increased,16334108
1,,22.0,General physical health deterioration,16334108
2,,22.0,Pain,16334108
3,,22.0,Decreased appetite,16334108
4,,22.0,Colon cancer,16334108
0,3,22.0,Hair colour changes,16334159
1,3,22.0,Hair disorder,16334159
2,3,22.0,Alopecia,16334159
3,3,22.0,Hair texture abnormal,16334159
4,3,22.0,Madarosis,16334159
0,3,22.1,Alopecia,16334161
1,3,22.1,Hair colour changes,16334161
2,3,22.1,Madarosis,16334161
3,3,22.1,Hair disorder,16334161
4,3,22.1,Hair texture abnormal,16334161
5,6,22.1,Depression,16334161
0,,22.0,Prostatic specific antigen increased,16334181
1,,22.0,Cognitive disorder,16334181
2,,22.0,Fatigue,16334181
3,5,22.0,Completed suicide,16334181
4,,22.0,Therapeutic response unexpected,16334181
0,3,22.0,Madarosis,16334197
1,3,22.0,Hair texture abnormal,16334197
2,3,22.0,Hair colour changes,16334197
3,3,22.0,Hair disorder,16334197
4,3,22.0,Alopecia,16334197
0,1,22.0,Ejection fraction decreased,16334215
0,4,22.0,Pneumonia,16334231
1,1,22.0,Depression,16334231
2,1,22.0,Tachycardia,16334231
3,1,22.0,Pyrexia,16334231
4,1,22.0,C-reactive protein increased,16334231
5,1,22.0,Anaemia of malignant disease,16334231
6,1,22.0,Oedema peripheral,16334231
7,5,22.0,Death,16334231
8,1,22.0,Hyperventilation,16334231
0,6,22.0,Hypertriglyceridaemia,16334256
1,6,22.0,Blood cholesterol increased,16334256
0,1,22.0,Gastritis,16334265
0,6,22.0,Weight decreased,16334274
1,2,22.0,Injection site erythema,16334274
2,3,22.0,Injection site oedema,16334274
3,6,22.0,Muscle atrophy,16334274
4,3,22.0,Injection site induration,16334274
5,3,22.0,Muscle spasms,16334274
0,6,22.0,Hepatotoxicity,16334276
1,6,22.0,Fatigue,16334276
2,6,22.0,Diarrhoea,16334276
3,6,22.0,Product use in unapproved indication,16334276
4,6,22.0,Bronchial obstruction,16334276
5,6,22.0,Off label use,16334276
0,6,22.0,Disease progression,16334300
1,1,22.0,Product use in unapproved indication,16334300
0,5,22.1,Death,16334301
1,6,22.1,Weight decreased,16334301
2,6,22.1,Chest wall tumour,16334301
3,6,22.1,Asthenia,16334301
4,1,22.1,Pyrexia,16334301
5,6,22.1,Nausea,16334301
6,6,22.1,General physical health deterioration,16334301
7,6,22.1,Feeding disorder,16334301
0,6,22.0,Product use in unapproved indication,16334303
1,3,22.0,Nausea,16334303
0,6,22.0,Electrolyte imbalance,16334304
1,6,22.0,Flushing,16334304
2,6,22.0,Abdominal discomfort,16334304
3,6,22.0,Burning sensation,16334304
4,6,22.0,Hypersensitivity,16334304
5,6,22.0,Peripheral swelling,16334304
6,6,22.0,Product use in unapproved indication,16334304
7,6,22.0,Pain in extremity,16334304
0,6,22.0,Product use in unapproved indication,16334305
1,6,22.0,Vomiting,16334305
0,1,22.0,Small intestinal obstruction,16334309
0,6,22.0,Product use in unapproved indication,16334313
1,2,22.0,Diarrhoea,16334313
2,2,22.0,Rash,16334313
0,6,22.0,Metastases to soft tissue,16334342
1,6,22.0,Metastasis,16334342
2,6,22.0,Breast cancer,16334342
3,6,22.0,Metastases to bone,16334342
4,6,22.0,Infection,16334342
5,6,22.0,Metastases to lung,16334342
6,6,22.0,Malignant neoplasm progression,16334342
7,6,22.0,Drug ineffective,16334342
0,5,22.0,Breast cancer metastatic,16334345
1,6,22.0,Off label use,16334345
2,3,22.0,Abdominal pain,16334345
0,6,22.0,Dehydration,16334368
1,6,22.0,Food poisoning,16334368
2,6,22.0,Vomiting,16334368
0,5,22.0,Metastases to lung,16334471
1,5,22.0,Respiratory failure,16334471
2,5,22.0,Breast cancer,16334471
3,5,22.0,Malignant neoplasm progression,16334471
4,5,22.0,Metastases to bone,16334471
5,5,22.0,Coma,16334471
6,5,22.0,Hepatic failure,16334471
7,5,22.0,Movement disorder,16334471
8,5,22.0,Renal failure,16334471
9,5,22.0,Pneumonia,16334471
10,5,22.0,Sepsis,16334471
11,5,22.0,Oliguria,16334471
12,5,22.0,Insomnia,16334471
0,6,22.0,Product use in unapproved indication,16334473
1,5,22.0,Death,16334473
0,5,22.0,Jaundice,16334476
1,5,22.0,Hepatic failure,16334476
2,6,22.0,Oedema,16334476
0,5,22.0,Death,16334486
0,5,22.0,Death,16334502
0,6,22.0,Abdominal distension,16334531
1,5,22.0,Death,16334531
0,6,22.0,Cataract,16334533
0,5,22.0,Malignant neoplasm progression,16334606
1,6,22.0,Product use in unapproved indication,16334606
2,5,22.0,Transitional cell cancer of the renal pelvis and ureter,16334606
3,5,22.0,Transitional cell carcinoma urethra,16334606
0,5,22.1,Disease progression,16334616
1,1,22.1,Diarrhoea,16334616
0,2,22.0,Delirium,16334704
1,6,22.0,Inadequate analgesia,16334704
0,6,22.0,No adverse event,16334735
0,3,22.0,Rash,16334742
1,5,22.0,Diverticulitis,16334742
2,3,22.0,Fatigue,16334742
3,5,22.0,Procedural complication,16334742
0,3,22.0,Angina pectoris,16334745
0,6,22.0,Blood glucose decreased,16334746
1,6,22.0,Blood pressure increased,16334746
2,6,22.0,Vitamin D decreased,16334746
3,6,22.0,Erythema,16334746
4,6,22.0,Dysphonia,16334746
5,6,22.0,Respiratory tract congestion,16334746
6,6,22.0,Hot flush,16334746
7,2,22.0,Palatal swelling,16334746
8,6,22.0,Blood potassium decreased,16334746
9,6,22.0,Blood magnesium decreased,16334746
10,6,22.0,Diarrhoea,16334746
11,6,22.0,Loss of consciousness,16334746
12,6,22.0,Blood calcium decreased,16334746
13,6,22.0,Stomatitis,16334746
0,3,22.0,Fatigue,16334785
1,3,22.0,Feeling abnormal,16334785
0,1,22.0,Anaemia,16334804
0,1,22.0,Myalgia,16334887
1,3,22.0,Iron deficiency,16334887
2,1,22.0,Paraesthesia,16334887
3,1,22.0,Neutropenia,16334887
4,1,22.0,Musculoskeletal pain,16334887
5,2,22.0,Febrile neutropenia,16334887
6,1,22.0,Neutropenia,16334887
7,3,22.0,Stoma site haemorrhage,16334887
8,1,22.0,Myalgia,16334887
9,1,22.0,Thrombocytopenia,16334887
10,1,22.0,Bone pain,16334887
11,1,22.0,Hypersensitivity,16334887
12,1,22.0,Altered state of consciousness,16334887
13,3,22.0,Fatigue,16334887
0,1,22.0,Gastritis,16334891
1,6,22.0,Myalgia,16334891
2,6,22.0,Fatigue,16334891
3,6,22.0,Pyrexia,16334891
4,2,22.0,Oesophagitis,16334891
5,6,22.0,Nausea,16334891
6,6,22.0,Vomiting,16334891
7,6,22.0,Abdominal pain,16334891
8,6,22.0,Diarrhoea,16334891
0,6,22.0,Blood pressure systolic increased,16334903
0,6,22.0,Granulocytopenia,16334921
1,6,22.0,Neoplasm progression,16334921
2,6,22.0,Anaemia,16334921
3,6,22.0,Dry skin,16334921
4,6,22.0,Leukopenia,16334921
5,6,22.0,Flushing,16334921
6,6,22.0,Alopecia,16334921
7,6,22.0,Fatigue,16334921
0,1,22.0,Nausea,16334927
1,1,22.0,Vomiting,16334927
2,6,22.0,Blood potassium decreased,16334927
3,3,22.0,Constipation,16334927
4,6,22.0,Apathy,16334927
5,3,22.0,Hypoaesthesia,16334927
6,3,22.0,Chills,16334927
7,6,22.0,White blood cell count decreased,16334927
8,6,22.0,Fall,16334927
9,5,22.0,Death,16334927
10,6,22.0,Metastases to central nervous system,16334927
11,1,22.0,Hyperhidrosis,16334927
12,3,22.0,Vomiting,16334927
13,3,22.0,Muscular weakness,16334927
14,3,22.0,Nausea,16334927
15,6,22.0,Inappropriate schedule of product administration,16334927
0,6,22.0,Meniere^s disease,16334931
1,6,22.0,Musculoskeletal stiffness,16334931
2,6,22.0,Dizziness,16334931
3,1,22.0,Diarrhoea,16334931
4,6,22.0,Decreased appetite,16334931
5,6,22.0,Blood pressure increased,16334931
6,6,22.0,Fatigue,16334931
0,1,22.0,Bone marrow failure,16335036
0,1,22.0,Dermatitis acneiform,16335045
1,1,22.0,Paronychia,16335045
2,1,22.0,Neuropathy peripheral,16335045
0,6,22.0,Diabetes mellitus,16335093
0,6,22.0,Central nervous system lesion,16335133
0,6,22.0,Nausea,16335160
1,6,22.0,Dizziness,16335160
2,1,22.0,Vomiting,16335160
0,6,22.0,Anaphylactic shock,16335175
0,2,22.0,Loss of consciousness,16335184
1,2,22.0,Hypovolaemic shock,16335184
0,2,22.0,Loss of consciousness,16335199
1,2,22.0,Chest discomfort,16335199
2,2,22.0,Oxygen saturation decreased,16335199
0,6,22.0,Drug intolerance,16335225
1,6,22.0,Decreased appetite,16335225
2,6,22.0,Nausea,16335225
0,6,22.0,Inappropriate schedule of product administration,16335263
1,6,22.0,Malignant neoplasm progression,16335263
2,6,22.0,Skin lesion,16335263
3,6,22.0,Breast cancer stage III,16335263
4,6,22.0,Dermatitis,16335263
5,6,22.0,Therapeutic response decreased,16335263
6,6,22.0,Metastases to skin,16335263
0,5,22.0,Death,16335349
0,1,22.0,Protein urine present,16335393
1,3,22.0,Blood urine present,16335393
0,1,22.0,Dyspnoea,16335418
1,1,22.0,Pneumocystis jirovecii pneumonia,16335418
0,6,22.0,Bone marrow failure,16335454
0,6,22.0,Drug hypersensitivity,16335458
1,6,22.0,Anaphylactic reaction,16335458
0,6,22.0,Toxic neuropathy,16335461
0,3,22.0,Bone pain,16335472
1,6,22.0,Product substitution issue,16335472
2,3,22.0,Dry mouth,16335472
3,3,22.0,Nausea,16335472
4,3,22.0,Fatigue,16335472
0,3,22.0,Drug ineffective,16335494
0,6,22.0,Hyperthermia,16335495
0,6,22.0,Cardiac failure,16335529
1,6,22.0,Atrial fibrillation,16335529
2,6,22.0,Discomfort,16335529
3,6,22.0,Chest discomfort,16335529
4,6,22.0,Dyspnoea,16335529
0,6,22.0,Product supply issue,16335555
1,6,22.0,Underdose,16335555
0,1,22.0,Gastrointestinal haemorrhage,16335558
1,2,22.0,Prostatic specific antigen increased,16335558
0,6,22.0,Cardiac failure congestive,16335580
1,6,22.0,Fatigue,16335580
2,6,22.0,Peripheral swelling,16335580
3,6,22.0,Decreased appetite,16335580
0,1,22.0,Cystitis,16335583
1,3,22.0,Sepsis,16335583
2,6,22.0,Product dose omission,16335583
0,3,22.1,Amaurosis,16335653
1,3,22.1,Optic neuritis,16335653
2,3,22.1,Visual impairment,16335653
3,3,22.1,Visual field defect,16335653
0,3,22.0,Toxicity to various agents,16335656
1,3,22.0,Pain in extremity,16335656
2,6,22.0,Hypoaesthesia,16335656
3,3,22.0,Paralysis,16335656
4,6,22.0,Vomiting,16335656
5,6,22.0,Confusional state,16335656
0,6,22.0,Pulmonary embolism,16335719
1,6,22.0,Asthenia,16335719
2,6,22.0,Neutropenia,16335719
3,6,22.0,Hepatotoxicity,16335719
0,3,22.0,Malaise,16335766
0,6,22.0,Gastrointestinal toxicity,16335770
1,6,22.0,Neurotoxicity,16335770
2,6,22.0,Lymphangiosis carcinomatosa,16335770
3,6,22.0,Liver function test increased,16335770
4,6,22.0,Asthenia,16335770
0,6,22.0,Malignant neoplasm progression,16335848
0,3,22.0,Tympanic membrane disorder,16335860
1,3,22.0,Deafness,16335860
2,3,22.0,Tinnitus,16335860
0,6,22.0,Muscle fatigue,16335934
1,6,22.0,Myopathy toxic,16335934
2,6,22.0,Maximal voluntary ventilation abnormal,16335934
3,6,22.0,Oxygen consumption decreased,16335934
4,6,22.0,Dyspnoea,16335934
5,6,22.0,Mitochondrial toxicity,16335934
6,6,22.0,Weight decreased,16335934
7,6,22.0,Muscle injury,16335934
0,6,22.0,Fanconi syndrome,16335947
1,6,22.0,Dehydration,16335947
2,6,22.0,Malignant neoplasm progression,16335947
3,6,22.0,Renal tubular disorder,16335947
4,6,22.0,Liver disorder,16335947
0,6,22.0,Hypothyroidism,16335982
1,6,22.0,Malignant neoplasm progression,16335982
2,6,22.0,Rash,16335982
0,2,22.0,Pneumothorax,16335987
1,6,22.0,Pneumothorax,16335987
0,6,22.0,Neutropenia,16336010
1,6,22.0,Drug interaction,16336010
0,6,22.0,Pulmonary fibrosis,16336023
0,6,22.0,Disease progression,16336063
1,6,22.0,Drug ineffective,16336063
0,3,22.0,Renal disorder,16336067
0,6,22.0,Bone marrow failure,16336086
0,2,22.0,Large intestine infection,16336106
1,2,22.0,Decreased appetite,16336106
2,2,22.0,Diarrhoea,16336106
3,2,22.0,Vomiting,16336106
0,1,22.0,Macroglossia,16336154
1,1,22.0,Paraesthesia,16336154
0,,22.0,Colon cancer,16336155
0,5,22.0,Colorectal cancer,16336157
0,6,22.0,Bone marrow failure,16336235
1,6,22.0,Renal impairment,16336235
0,2,22.0,Taste disorder,16336243
1,6,22.0,Cerebrovascular accident,16336243
2,2,22.0,Decreased appetite,16336243
3,6,22.0,Osteoporosis,16336243
4,3,22.0,Hot flush,16336243
5,6,22.0,Transient ischaemic attack,16336243
6,2,22.0,Nausea,16336243
0,1,22.0,Gait disturbance,16336274
1,1,22.0,Proteinuria,16336274
2,1,22.0,Weight decreased,16336274
3,1,22.0,Neutrophilia,16336274
4,1,22.0,Decreased appetite,16336274
5,1,22.0,Hypercreatinaemia,16336274
6,1,22.0,Leukocytosis,16336274
7,1,22.0,Asthenia,16336274
8,1,22.0,Dyspnoea,16336274
0,1,22.0,Weight decreased,16336296
1,1,22.0,Decreased appetite,16336296
2,1,22.0,Proteinuria,16336296
3,1,22.0,Gait disturbance,16336296
4,1,22.0,Dyspnoea,16336296
5,1,22.0,Neutrophilia,16336296
6,1,22.0,Leukocytosis,16336296
7,1,22.0,Asthenia,16336296
8,1,22.0,Hypercreatinaemia,16336296
0,6,22.0,Application site haemorrhage,16336297
1,6,22.0,Application site pain,16336297
2,6,22.0,Wrong technique in product usage process,16336297
0,5,22.0,Death,16336311
0,6,22.0,Off label use,16336319
1,6,22.0,Intentional product use issue,16336319
2,6,22.0,Fatigue,16336319
3,6,22.0,Drug intolerance,16336319
4,6,22.0,Pyrexia,16336319
5,6,22.0,Headache,16336319
6,6,22.0,Bone marrow failure,16336319
0,1,22.0,Perioral dermatitis,16336321
1,1,22.0,Rash,16336321
0,1,22.0,Gait disturbance,16336340
1,6,22.0,Confusional state,16336340
2,1,22.0,Injection site pain,16336340
3,1,22.0,Pneumonia,16336340
4,1,22.0,Dysstasia,16336340
5,1,22.0,Asthenia,16336340
6,6,22.0,Speech disorder,16336340
7,1,22.0,Disorientation,16336340
0,6,22.0,Myocardial infarction,16336390
1,6,22.0,Chest pain,16336390
2,6,22.0,Conduction disorder,16336390
3,6,22.0,Cardiac failure,16336390
4,6,22.0,Atrioventricular block complete,16336390
5,6,22.0,Atrial fibrillation,16336390
6,6,22.0,Acute coronary syndrome,16336390
7,6,22.0,Cardiac arrest,16336390
8,6,22.0,Left ventricular dysfunction,16336390
0,2,22.0,Lacrimation increased,16336415
1,2,22.0,Pain in extremity,16336415
2,2,22.0,Muscle spasms,16336415
0,,22.0,Rash,16336497
0,1,22.0,Dysarthria,16336499
1,6,22.0,Bone marrow failure,16336499
0,1,22.0,Infection,16336503
1,1,22.0,Skin ulcer,16336503
2,1,22.0,Pyrexia,16336503
0,6,22.0,Breast cancer metastatic,16336589
1,6,22.0,Malignant neoplasm progression,16336589
0,6,22.0,Product use complaint,16336615
1,6,22.0,Dementia,16336615
2,6,22.0,Prostatic specific antigen increased,16336615
0,1,22.0,Feeling hot,16336639
1,1,22.0,Dyspnoea,16336639
2,1,22.0,Oxygen saturation decreased,16336639
0,1,22.0,Tachycardia,16336640
1,1,22.0,Pruritus,16336640
2,1,22.0,Erythema,16336640
3,1,22.0,Dyspnoea,16336640
0,6,22.0,Cardiotoxicity,16336644
0,6,22.0,Colitis ischaemic,16336662
0,,22.0,Dehydration,16336664
0,6,22.0,Product use in unapproved indication,16336699
1,6,22.0,Arthralgia,16336699
2,6,22.0,Back pain,16336699
3,6,22.0,Diarrhoea,16336699
0,5,22.0,Death,16336769
0,5,22.0,Death,16336789
0,6,22.0,Blood test abnormal,16336815
0,6,22.0,Dehydration,16336816
1,6,22.0,Abdominal distension,16336816
2,6,22.0,Blood count abnormal,16336816
3,6,22.0,Disease progression,16336816
0,6,22.0,Hepatic cancer,16336844
1,6,22.0,Condition aggravated,16336844
2,6,22.0,Unevaluable event,16336844
3,6,22.0,Liver injury,16336844
4,6,22.0,Liver disorder,16336844
0,1,22.0,Acute coronary syndrome,16336845
0,2,22.0,Rhabdomyolysis,16336861
0,,22.0,Death,16336879
0,1,22.0,Hypotension,16336889
1,1,22.0,Dyspnoea,16336889
2,1,22.0,Defaecation urgency,16336889
3,1,22.0,Tachycardia,16336889
0,3,22.0,Immune-mediated adverse reaction,16336934
1,6,22.0,Intracranial pressure increased,16336934
2,6,22.0,Hypothyroidism,16336934
3,3,22.0,Feeling hot,16336934
4,3,22.0,Eye pruritus,16336934
0,6,22.0,Rhabdomyolysis,16336941
0,6,22.0,Deafness,16336946
0,6,22.0,Deafness,16336950
0,6,22.0,Deafness,16336952
0,6,22.0,Deafness,16336978
0,6,22.0,Deafness,16336979
0,6,22.0,Deafness,16336980
0,6,22.0,Drug interaction,16337005
1,3,22.0,Oesophagitis,16337005
2,6,22.0,Drug ineffective,16337005
3,3,22.0,Gastritis erosive,16337005
0,1,22.0,Immune-mediated adverse reaction,16337015
1,1,22.0,Infusion related reaction,16337015
2,1,22.0,Infusion related reaction,16337015
3,1,22.0,Immune-mediated adverse reaction,16337015
0,1,22.0,Infectious pleural effusion,16337052
0,6,22.0,Colorectal cancer metastatic,16337062
0,1,22.0,Pruritus,16337084
1,1,22.0,Urticaria,16337084
0,2,22.0,White blood cell count decreased,16337095
0,6,22.1,Musculoskeletal stiffness,16337100
1,1,22.1,Dyspnoea,16337100
2,3,22.1,Urinary tract infection,16337100
3,6,22.1,White blood cells urine positive,16337100
4,6,22.1,Muscle spasms,16337100
5,6,22.1,Blood pressure diastolic increased,16337100
6,6,22.1,Bone marrow failure,16337100
7,6,22.1,Pyrexia,16337100
8,1,22.1,Vomiting,16337100
9,1,22.1,Red blood cell count increased,16337100
10,6,22.1,Abdominal discomfort,16337100
11,1,22.1,Insomnia,16337100
12,3,22.1,Fatigue,16337100
13,1,22.1,Tachycardia,16337100
14,1,22.1,Nausea,16337100
15,6,22.1,Limb discomfort,16337100
16,1,22.1,White blood cell count decreased,16337100
17,1,22.1,Hypertension,16337100
0,3,22.0,Madarosis,16337114
1,3,22.0,Alopecia,16337114
0,6,22.1,Asthenia,16337118
1,6,22.1,Nausea,16337118
2,6,22.1,Dry mouth,16337118
3,6,22.1,Headache,16337118
4,6,22.1,Vomiting,16337118
5,6,22.1,Catarrh,16337118
6,6,22.1,Fatigue,16337118
7,6,22.1,Constipation,16337118
8,6,22.1,Alopecia,16337118
9,6,22.1,Abdominal discomfort,16337118
10,6,22.1,Pyrexia,16337118
11,6,22.1,White blood cell count decreased,16337118
0,6,22.1,Anxiety,16337139
1,3,22.1,Fatigue,16337139
2,3,22.1,Depression,16337139
3,6,22.1,Decreased appetite,16337139
4,6,22.1,Fall,16337139
5,6,22.1,Osteogenesis imperfecta,16337139
6,6,22.1,Weight decreased,16337139
7,6,22.1,Stomatitis,16337139
8,6,22.1,Skin lesion,16337139
9,3,22.1,Tremor,16337139
10,6,22.1,Rhinorrhoea,16337139
0,6,22.0,Vomiting,16337146
1,6,22.0,Nausea,16337146
2,6,22.0,Diarrhoea,16337146
0,6,22.0,Abdominal discomfort,16337148
1,6,22.0,Vomiting,16337148
2,6,22.0,Diarrhoea,16337148
3,6,22.0,Nausea,16337148
4,6,22.0,Abdominal pain upper,16337148
0,1,22.0,Renal tubular necrosis,16337164
1,1,22.0,Acute kidney injury,16337164
0,3,22.0,Platelet count decreased,16337175
1,6,22.0,Full blood count decreased,16337175
2,3,22.0,Haemoglobin decreased,16337175
3,6,22.0,Fatigue,16337175
0,6,22.1,Dehydration,16337176
1,6,22.1,Contusion,16337176
2,6,22.1,Discomfort,16337176
3,3,22.1,Insomnia,16337176
4,3,22.1,Condition aggravated,16337176
5,3,22.1,Frequent bowel movements,16337176
6,3,22.1,Dizziness,16337176
7,3,22.1,Headache,16337176
8,6,22.1,Heart rate increased,16337176
9,6,22.1,Mass,16337176
10,6,22.1,Pollakiuria,16337176
11,3,22.1,Skin discolouration,16337176
12,6,22.1,Metrorrhagia,16337176
13,6,22.1,Muscle spasms,16337176
14,6,22.1,Pain in extremity,16337176
15,6,22.1,Infection,16337176
16,3,22.1,Decreased appetite,16337176
17,3,22.1,Vomiting,16337176
18,3,22.1,Nausea,16337176
19,6,22.1,Hospitalisation,16337176
20,3,22.1,Haemoglobin decreased,16337176
21,2,22.1,Pain,16337176
22,3,22.1,Feeling jittery,16337176
23,3,22.1,Feeling cold,16337176
24,6,22.1,Vertigo,16337176
25,6,22.1,Dry mouth,16337176
26,3,22.1,Anxiety,16337176
27,6,22.1,Gait disturbance,16337176
28,3,22.1,Neuropathy peripheral,16337176
29,6,22.1,Full blood count decreased,16337176
30,3,22.1,Platelet count decreased,16337176
31,2,22.1,Chest pain,16337176
32,6,22.1,Parkinson^s disease,16337176
33,6,22.1,Malaise,16337176
34,3,22.1,Asthenia,16337176
35,3,22.1,Fatigue,16337176
36,6,22.1,Haemorrhage,16337176
37,6,22.1,Weight increased,16337176
38,3,22.1,Abdominal pain upper,16337176
0,6,22.0,Drug ineffective,16337272
1,1,22.0,Oesophageal varices haemorrhage,16337272
2,1,22.0,Upper gastrointestinal haemorrhage,16337272
3,6,22.0,Condition aggravated,16337272
4,6,22.0,Vomiting,16337272
5,6,22.0,Fatigue,16337272
0,5,22.0,Bone marrow failure,16337283
1,1,22.0,Myelodysplastic syndrome,16337283
0,1,22.0,Febrile neutropenia,16337288
1,1,22.0,Rash,16337288
2,1,22.0,Liver function test abnormal,16337288
0,6,22.0,Fatigue,16337298
1,6,22.0,Stomatitis,16337298
0,6,22.0,Dysstasia,16337300
1,6,22.0,Pain,16337300
0,3,22.0,Hair texture abnormal,16337326
1,3,22.0,Hair colour changes,16337326
2,3,22.0,Hair disorder,16337326
3,3,22.0,Alopecia,16337326
4,3,22.0,Madarosis,16337326
0,,22.0,Abdominal pain,16337329
1,,22.0,Diarrhoea,16337329
0,6,22.1,Product dose omission,16337381
1,6,22.1,Thrombosis,16337381
0,3,22.0,Hyperhidrosis,16337395
1,6,22.0,Nephrolithiasis,16337395
2,6,22.0,Hot flush,16337395
0,2,22.0,Dermatitis bullous,16337397
1,2,22.0,Angioedema,16337397
2,6,22.0,Drug ineffective,16337397
3,2,22.0,Skin lesion,16337397
4,2,22.0,Intertrigo,16337397
0,3,22.0,Feeling abnormal,16337421
0,3,22.1,Hair texture abnormal,16337423
1,3,22.1,Hair colour changes,16337423
2,3,22.1,Madarosis,16337423
3,3,22.1,Alopecia,16337423
4,3,22.1,Hair disorder,16337423
0,6,22.0,Nipple disorder,16337471
0,,22.0,Nephrolithiasis,16337477
0,2,22.0,Metastases to liver,16337487
1,2,22.0,Retroperitoneal cancer,16337487
2,3,22.0,Thrombocytosis,16337487
3,1,22.0,Anaemia,16337487
4,6,22.0,Off label use,16337487
5,2,22.0,Malignant neoplasm progression,16337487
6,1,22.0,Second primary malignancy,16337487
7,6,22.0,Product use in unapproved indication,16337487
8,1,22.0,Myelodysplastic syndrome,16337487
9,1,22.0,Diarrhoea,16337487
0,6,22.0,Constipation,16337497
1,6,22.0,White blood cell count decreased,16337497
2,6,22.0,Blood creatinine increased,16337497
0,6,22.0,Dyspnoea,16337498
1,6,22.0,Atrial fibrillation,16337498
2,6,22.0,Chest discomfort,16337498
3,6,22.0,Discomfort,16337498
4,6,22.0,Cardiac failure,16337498
0,3,22.0,Lacrimation increased,16337573
1,6,22.0,Product use in unapproved indication,16337573
2,3,22.0,Eye irritation,16337573
0,1,22.0,Neutrophil count decreased,16337592
1,1,22.0,Cellulitis,16337592
2,1,22.0,Lethargy,16337592
3,1,22.0,Myalgia,16337592
4,1,22.0,Nausea,16337592
0,2,22.0,Hypotension,16337595
1,2,22.0,Band sensation,16337595
0,2,22.0,Loss of consciousness,16337611
0,1,22.1,Abdominal pain,16337636
1,1,22.1,Prostatic obstruction,16337636
2,3,22.1,Memory impairment,16337636
3,1,22.1,Pollakiuria,16337636
4,1,22.1,Urinary retention,16337636
5,1,22.1,Ureteric obstruction,16337636
0,6,22.0,Blood bilirubin increased,16337640
1,3,22.0,Abdominal discomfort,16337640
2,6,22.0,Haematocrit decreased,16337640
3,6,22.0,Renal impairment,16337640
4,6,22.0,Liver function test increased,16337640
5,1,22.0,Platelet count decreased,16337640
6,6,22.0,Blood bilirubin unconjugated increased,16337640
7,6,22.0,Blood creatinine increased,16337640
8,6,22.0,Hepatic function abnormal,16337640
9,6,22.0,Blood cholesterol increased,16337640
10,3,22.0,Chest discomfort,16337640
11,6,22.0,Back pain,16337640
12,6,22.0,Alanine aminotransferase increased,16337640
13,6,22.0,Fatigue,16337640
14,6,22.0,Aspartate aminotransferase increased,16337640
15,6,22.0,Bilirubin conjugated increased,16337640
16,6,22.0,Blood uric acid increased,16337640
0,3,22.0,Terminal state,16337665
1,6,22.0,Gait inability,16337665
2,3,22.0,General physical health deterioration,16337665
3,6,22.0,Malaise,16337665
4,6,22.0,Feeling abnormal,16337665
5,6,22.0,Insomnia,16337665
6,6,22.0,Seizure,16337665
7,6,22.0,Vomiting,16337665
8,6,22.0,Pyrexia,16337665
9,6,22.0,Osteoporosis,16337665
10,6,22.0,Memory impairment,16337665
11,6,22.0,Speech disorder,16337665
12,6,22.0,Joint injury,16337665
13,6,22.0,Dizziness,16337665
14,6,22.0,Acne,16337665
15,6,22.0,Brain neoplasm,16337665
16,6,22.0,Eating disorder,16337665
17,6,22.0,Weight decreased,16337665
18,6,22.0,Dry skin,16337665
19,6,22.0,Headache,16337665
20,6,22.0,Nausea,16337665
21,6,22.0,Fluid retention,16337665
22,6,22.0,Drug intolerance,16337665
23,6,22.0,CSF volume increased,16337665
24,6,22.0,Boredom,16337665
25,6,22.0,Hypersensitivity,16337665
0,1,22.0,Neutropenia,16337666
1,3,22.0,Polyneuropathy,16337666
2,1,22.0,Neutropenia,16337666
0,6,22.0,Tenderness,16337667
1,6,22.0,Dysgeusia,16337667
2,6,22.0,Stomatitis,16337667
3,6,22.0,Peripheral swelling,16337667
4,6,22.0,Blood count abnormal,16337667
5,6,22.0,Decreased appetite,16337667
0,6,22.1,Pigmentation disorder,16337692
1,6,22.1,Fatigue,16337692
2,6,22.1,Pruritus,16337692
3,6,22.1,Thrombosis,16337692
4,6,22.1,Ageusia,16337692
5,6,22.1,Diarrhoea,16337692
6,6,22.1,Nausea,16337692
7,6,22.1,Sensitive skin,16337692
0,3,22.1,Infectious pleural effusion,16337695
1,6,22.1,Malignant neoplasm progression,16337695
2,5,22.1,Sepsis,16337695
0,6,22.0,Atrial fibrillation,16337729
0,6,22.0,Hypersensitivity vasculitis,16337730
1,6,22.0,Arthritis,16337730
0,5,22.0,Pneumonia,16337731
1,2,22.0,Perivascular dermatitis,16337731
0,1,22.1,Drug reaction with eosinophilia and systemic symptoms,16337734
0,6,22.0,Immune-mediated hepatitis,16337738
1,6,22.0,Hypersensitivity vasculitis,16337738
0,3,22.1,Haemorrhage,16337745
1,3,22.1,Feeling hot,16337745
2,2,22.1,Rhinorrhoea,16337745
3,6,22.1,Swelling,16337745
4,3,22.1,Neck pain,16337745
5,3,22.1,Thyroid disorder,16337745
6,3,22.1,Vomiting,16337745
7,3,22.1,Fatigue,16337745
8,6,22.1,Nausea,16337745
9,3,22.1,Hyperhidrosis,16337745
0,6,22.0,Urosepsis,16337757
1,6,22.0,Renal failure,16337757
2,6,22.0,Ascites,16337757
3,6,22.0,Hepatic cirrhosis,16337757
4,6,22.0,Renal tubular necrosis,16337757
5,6,22.0,Hydronephrosis,16337757
6,6,22.0,Deep vein thrombosis,16337757
7,6,22.0,Eye haemorrhage,16337757
8,6,22.0,Arrhythmia,16337757
0,6,22.1,Urinary tract infection,16337772
1,6,22.1,Pyrexia,16337772
2,6,22.1,Blood pressure decreased,16337772
3,2,22.1,Bacterial infection,16337772
0,3,22.0,Gamma-glutamyltransferase increased,16337784
1,3,22.0,Blood bilirubin increased,16337784
2,3,22.0,Aspartate aminotransferase increased,16337784
3,5,22.0,Malignant neoplasm progression,16337784
4,3,22.0,Blood alkaline phosphatase increased,16337784
5,3,22.0,Alanine aminotransferase increased,16337784
6,3,22.0,Blood lactate dehydrogenase increased,16337784
0,1,22.0,Cataract,16337790
0,6,22.1,No adverse event,16337803
0,5,22.0,Death,16337816
1,6,22.0,Product use in unapproved indication,16337816
0,5,22.0,Death,16337819
1,6,22.0,Product use in unapproved indication,16337819
0,1,22.1,Duodenitis,16337824
1,2,22.1,Vomiting,16337824
2,1,22.1,Colitis,16337824
3,5,22.1,Hepatic failure,16337824
4,6,22.1,Liver abscess,16337824
5,6,22.1,Prescribed overdose,16337824
6,5,22.1,Cholangitis sclerosing,16337824
7,2,22.1,Nausea,16337824
8,6,22.1,Escherichia infection,16337824
9,6,22.1,Coma hepatic,16337824
10,6,22.1,Respiratory disorder,16337824
0,6,22.0,Intentional product use issue,16337836
1,6,22.0,Adverse event,16337836
0,6,22.0,Fistula,16337892
0,5,22.0,Malignant neoplasm progression,16337906
0,6,22.0,Acute myocardial infarction,16337918
0,6,22.0,Adverse event,16337936
0,6,22.0,Malignant neoplasm progression,16338012
0,2,22.1,IIIrd nerve paralysis,16338029
0,6,22.0,Oral disorder,16338054
0,1,22.0,Liver injury,16338059
0,3,22.1,Alopecia,16338117
1,3,22.1,Lacrimation increased,16338117
2,6,22.1,Immune system disorder,16338117
0,1,22.1,Blood creatinine increased,16338120
0,1,22.1,Nausea,16338161
1,1,22.1,Taste disorder,16338161
2,6,22.1,Malignant neoplasm progression,16338161
3,1,22.1,Blood creatinine increased,16338161
4,1,22.1,Malaise,16338161
0,1,22.0,Urinary tract infection,16338162
0,5,22.0,Death,16338323
1,6,22.0,Sepsis,16338323
2,6,22.0,Cardiac arrest,16338323
0,,22.0,Blood count abnormal,16338329
1,,22.0,Off label use,16338329
0,2,22.0,Pre-existing condition improved,16338366
1,2,22.0,Dyspnoea,16338366
2,5,22.0,Metastases to central nervous system,16338366
3,,22.0,Anxiety,16338366
4,,22.0,Off label use,16338366
5,,22.0,General physical health deterioration,16338366
6,5,22.0,Colorectal cancer metastatic,16338366
7,,22.0,Hypertension,16338366
0,,22.0,Melaena,16338367
1,,22.0,Colon cancer,16338367
0,3,22.0,Hepatic enzyme increased,16338449
0,1,22.1,Thrombocytopenia,16338452
1,1,22.1,Intestinal obstruction,16338452
2,6,22.1,Malignant neoplasm progression,16338452
3,1,22.1,Erythropenia,16338452
0,1,22.0,Embolism,16338561
1,1,22.0,Pulmonary embolism,16338561
0,1,22.0,Thrombocytopenic purpura,16338568
0,,22.0,Femur fracture,16338573
1,,22.0,Prostatic specific antigen increased,16338573
2,,22.0,Fall,16338573
3,,22.0,Fatigue,16338573
0,,22.0,Fatigue,16338579
1,,22.0,Diarrhoea,16338579
2,,22.0,Prostatic specific antigen increased,16338579
0,5,22.0,Death,16338604
0,6,22.1,Off label use,16338606
1,5,22.1,Death,16338606
0,6,22.0,Dermatitis,16338614
1,6,22.0,Haematotoxicity,16338614
0,6,22.0,No adverse event,16338622
0,3,22.0,Gastrointestinal haemorrhage,16338663
1,1,22.0,Hypertension,16338663
2,3,22.0,Hepatic enzyme increased,16338663
3,1,22.0,Abdominal distension,16338663
4,1,22.0,Peripheral swelling,16338663
5,1,22.0,Acne,16338663
6,2,22.0,Skin discolouration,16338663
7,3,22.0,Dysphonia,16338663
8,3,22.0,Asthenia,16338663
0,6,22.0,Prostate cancer metastatic,16338670
1,6,22.0,Malignant neoplasm progression,16338670
0,6,22.0,Vomiting,16338673
1,2,22.0,Sinus tachycardia,16338673
2,2,22.0,Dyspnoea,16338673
0,2,22.0,Abdominal abscess,16338706
0,2,22.0,Wound dehiscence,16338724
0,1,22.0,Lung infection,16338736
0,1,22.0,Asthenia,16338763
1,1,22.0,Leukocytosis,16338763
2,1,22.0,Hypercreatinaemia,16338763
3,1,22.0,Neutrophilia,16338763
4,1,22.0,Proteinuria,16338763
5,1,22.0,Dyspnoea,16338763
6,1,22.0,Weight decreased,16338763
7,1,22.0,Decreased appetite,16338763
8,1,22.0,Gait disturbance,16338763
0,3,22.0,Neuropathy peripheral,16338776
1,3,22.0,Skin atrophy,16338776
2,3,22.0,Palmar-plantar erythrodysaesthesia syndrome,16338776
0,3,22.0,Abdominal pain upper,16338785
0,5,22.0,Malignant neoplasm progression,16338786
0,3,22.0,Proteinuria,16338826
1,3,22.0,Blood creatinine increased,16338826
2,3,22.0,Acute kidney injury,16338826
3,3,22.0,Renal tubular injury,16338826
0,6,22.0,Alanine aminotransferase increased,16338835
1,6,22.0,Blood lactate dehydrogenase increased,16338835
2,6,22.0,Gamma-glutamyltransferase increased,16338835
3,6,22.0,Blood alkaline phosphatase increased,16338835
4,3,22.0,Hepatic enzyme increased,16338835
5,6,22.0,Aspartate aminotransferase increased,16338835
0,3,22.0,Paraesthesia,16338839
1,3,22.0,Nausea,16338839
2,3,22.0,Hypertransaminasaemia,16338839
3,3,22.0,Diarrhoea,16338839
4,3,22.0,Thrombocytopenia,16338839
0,4,22.0,Cerebrovascular accident,16338941
0,3,22.1,Diffuse alopecia,16338951
1,1,22.1,Atrial fibrillation,16338951
2,3,22.1,Nausea,16338951
3,1,22.1,Fall,16338951
4,3,22.1,Hot flush,16338951
5,1,22.1,Contusion,16338951
0,1,22.0,Dyspnoea,16338975
1,3,22.0,Blood pressure increased,16338975
2,3,22.0,Thirst,16338975
3,3,22.0,Asthenia,16338975
4,3,22.0,Dry mouth,16338975
5,3,22.0,Fatigue,16338975
6,1,22.0,Peripheral swelling,16338975
7,3,22.0,Oropharyngeal pain,16338975
8,3,22.0,Dysphagia,16338975
9,2,22.0,Decreased appetite,16338975
10,3,22.0,Dysphonia,16338975
11,3,22.0,Proteinuria,16338975
0,6,22.0,Alopecia,16338977
1,3,22.0,Bone marrow failure,16338977
0,5,22.0,Death,16338992
0,3,22.1,Madarosis,16339059
1,3,22.1,Hair colour changes,16339059
2,3,22.1,Hair disorder,16339059
3,3,22.1,Hair texture abnormal,16339059
4,3,22.1,Alopecia,16339059
0,6,22.0,Product dose omission,16339065
1,6,22.0,Lethargy,16339065
2,6,22.0,Fatigue,16339065
0,6,22.1,Nephritis,16339100
0,3,22.0,Bladder disorder,16339129
0,6,22.0,Unevaluable event,16339150
1,6,22.0,Pericardial effusion,16339150
0,1,22.0,Myocardial infarction,16339157
0,3,22.0,Dyspnoea,16339186
1,5,22.0,Pneumonia pneumococcal,16339186
0,5,22.1,Sudden death,16339196
1,1,22.1,Fatigue,16339196
2,1,22.1,Weight decreased,16339196
3,6,22.1,Hypertension,16339196
4,3,22.1,Dizziness,16339196
5,1,22.1,Decreased appetite,16339196
0,6,22.0,Hypersomnia,16339240
0,6,22.0,Second primary malignancy,16339291
1,6,22.0,Brain neoplasm,16339291
2,6,22.0,Confusional state,16339291
0,6,22.0,Breast cancer metastatic,16339299
1,6,22.0,Malignant neoplasm progression,16339299
0,1,22.1,Ejection fraction decreased,16339339
1,6,22.1,Chest discomfort,16339339
2,6,22.1,Myocardial ischaemia,16339339
3,6,22.1,Fatigue,16339339
4,5,22.1,Hepatic function abnormal,16339339
5,6,22.1,Ventricular hypokinesia,16339339
6,6,22.1,Dyspnoea,16339339
7,1,22.1,Cardiotoxicity,16339339
0,2,22.0,Alopecia,16339353
0,6,22.0,Alopecia,16339370
1,6,22.0,Psychological trauma,16339370
0,6,22.0,Alopecia,16339389
1,6,22.0,Psychological trauma,16339389
0,6,22.1,Anxiety,16339399
1,6,22.1,Pain,16339399
2,3,22.1,Alopecia,16339399
3,6,22.1,Psychological trauma,16339399
4,6,22.1,Impaired quality of life,16339399
5,6,22.1,Emotional distress,16339399
0,3,22.0,Alopecia,16339412
1,6,22.0,Psychological trauma,16339412
0,2,22.0,Alopecia,16339418
0,2,22.1,Alopecia,16339424
0,2,22.0,Alopecia,16339426
1,6,22.0,Psychological trauma,16339426
0,6,22.0,Psychological trauma,16339433
1,3,22.0,Alopecia,16339433
0,6,22.0,Cellulitis,16339443
1,6,22.0,Fasciitis,16339443
0,1,22.0,Glomerular filtration rate decreased,16339444
0,6,22.0,Peripheral sensory neuropathy,16339445
1,6,22.0,Alopecia,16339445
2,6,22.0,Neutropenia,16339445
3,6,22.0,Anaemia,16339445
4,6,22.0,Thrombocytopenia,16339445
0,6,22.1,Psychological trauma,16339520
1,2,22.1,Alopecia,16339520
0,6,22.0,Psychological trauma,16339620
1,2,22.0,Alopecia,16339620
0,,22.0,Off label use,16339661
1,3,22.0,Intensive care,16339661
0,5,22.1,Interstitial lung disease,16339693
1,1,22.1,Malaise,16339693
2,6,22.1,Blood glucose increased,16339693
3,6,22.1,Pulmonary embolism,16339693
4,6,22.1,Atypical mycobacterial infection,16339693
5,2,22.1,Diarrhoea,16339693
0,6,22.0,Nausea,16339906
1,6,22.0,Insomnia,16339906
2,3,22.0,Metastases to central nervous system,16339906
3,6,22.0,Underdose,16339906
4,6,22.0,Carbohydrate antigen 125 increased,16339906
0,6,22.0,Sinusitis,16339919
1,6,22.0,Malaise,16339919
2,3,22.0,Headache,16339919
3,3,22.0,Pyrexia,16339919
4,6,22.0,Nausea,16339919
5,6,22.0,Underdose,16339919
6,3,22.0,Rhinorrhoea,16339919
7,6,22.0,Intracranial pressure increased,16339919
8,6,22.0,Madarosis,16339919
9,3,22.0,Nasopharyngitis,16339919
10,6,22.0,Product dose omission,16339919
0,6,22.0,Compression fracture,16339923
1,6,22.0,Ascites,16339923
0,6,22.0,Gastrointestinal disorder,16339925
1,6,22.0,Bone marrow failure,16339925
0,6,22.1,Ill-defined disorder,16339927
1,6,22.1,Gastric infection,16339927
2,1,22.1,Dehydration,16339927
3,1,22.1,Vomiting,16339927
4,6,22.1,Product dose omission,16339927
5,6,22.1,Intentional dose omission,16339927
6,6,22.1,Hospitalisation,16339927
7,2,22.1,Dyspepsia,16339927
8,6,22.1,Asthenia,16339927
9,1,22.1,Abdominal pain upper,16339927
10,2,22.1,Weight decreased,16339927
11,1,22.1,Hypotension,16339927
12,6,22.1,Irritability,16339927
13,2,22.1,Insomnia,16339927
14,3,22.1,Fatigue,16339927
15,6,22.1,Hypersensitivity,16339927
0,6,22.0,Bone marrow failure,16339928
1,6,22.0,Gastrointestinal disorder,16339928
0,6,22.0,Nephrolithiasis,16339938
0,5,22.0,Death,16339941
0,6,22.0,Malignant neoplasm progression,16340004
1,1,22.0,Off label use,16340004
2,1,22.0,Product use in unapproved indication,16340004
0,2,22.0,Colitis,16340037
1,3,22.0,Renal impairment,16340037
0,6,22.0,Extravasation,16340056
0,2,22.0,Bone marrow failure,16340090
0,6,22.1,Electrocardiogram QT prolonged,16340115
0,1,22.1,Diarrhoea,16340118
1,1,22.1,Ventricular extrasystoles,16340118
2,6,22.1,Dry skin,16340118
3,1,22.1,Neutropenia,16340118
4,1,22.1,Atrial fibrillation,16340118
0,1,22.1,Sepsis,16340264
1,6,22.1,Guillain-Barre syndrome,16340264
0,5,22.0,Death,16340275
0,1,22.0,Coma,16340284
1,1,22.0,Seizure,16340284
2,1,22.0,Hypersensitivity,16340284
0,6,22.0,Neutrophil count decreased,16340286
1,1,22.0,Stomatitis,16340286
0,6,22.0,Bone marrow failure,16340351
1,2,22.0,Dysarthria,16340351
2,1,22.0,Dysarthria,16340351
0,1,22.0,Interstitial lung disease,16340393
0,6,22.0,Ear deformity acquired,16340398
1,6,22.0,Chondritis,16340398
0,6,22.0,Jugular vein thrombosis,16340556
1,3,22.0,Epistaxis,16340556
2,1,22.0,Muscle spasms,16340556
3,1,22.0,Nail toxicity,16340556
4,1,22.0,Upper respiratory tract infection,16340556
5,6,22.0,Sneezing,16340556
6,1,22.0,Pruritus,16340556
7,3,22.0,Polyneuropathy,16340556
8,1,22.0,Pyrexia,16340556
9,1,22.0,Hypertension,16340556
10,1,22.0,Toxic epidermal necrolysis,16340556
11,3,22.0,Diarrhoea,16340556
12,6,22.0,Prescribed underdose,16340556
0,2,22.0,Erythema multiforme,16340594
0,5,22.0,Myocarditis,16340596
0,6,22.0,Subdural haematoma,16340628
1,6,22.0,Vision blurred,16340628
2,6,22.0,Fall,16340628
3,6,22.0,Decreased activity,16340628
4,2,22.0,Dizziness,16340628
5,2,22.0,Muscular weakness,16340628
0,1,22.0,Cerebrospinal fluid leakage,16340636
1,1,22.0,Pneumocephalus,16340636
0,6,22.0,Memory impairment,16340654
1,6,22.0,Bradyphrenia,16340654
0,6,22.0,Calculus bladder,16340658
0,6,22.0,Epistaxis,16340668
1,2,22.0,Hyperthyroidism,16340668
2,6,22.0,Atrial flutter,16340668
3,6,22.0,Anaemia,16340668
4,2,22.0,Thyroiditis,16340668
5,6,22.0,Thyroid dermatopathy,16340668
0,6,22.0,Abdominal pain upper,16340676
1,6,22.0,Muscle spasms,16340676
2,6,22.0,Nausea,16340676
3,6,22.0,Blood phosphorus decreased,16340676
4,6,22.0,Blood calcium decreased,16340676
5,6,22.0,Vomiting,16340676
0,1,22.0,Dyspnoea,16340698
1,1,22.0,Flushing,16340698
2,1,22.0,Laryngospasm,16340698
0,5,22.0,Death,16340728
0,6,22.0,Drug-induced liver injury,16340730
1,1,22.0,Pericarditis malignant,16340730
0,6,22.0,Arthritis,16340767
1,6,22.0,Intentional product use issue,16340767
2,6,22.0,Off label use,16340767
0,5,22.0,Off label use,16340790
1,5,22.0,Product use issue,16340790
2,5,22.0,Neoplasm progression,16340790
0,3,22.0,Osteonecrosis of jaw,16340820
0,1,22.1,Chronic obstructive pulmonary disease,16340868
0,1,22.0,Acute kidney injury,16340947
0,1,22.0,Gastrointestinal inflammation,16340958
1,1,22.0,Tinea infection,16340958
0,2,22.0,Mucosal inflammation,16340977
1,2,22.0,Weight decreased,16340977
2,2,22.0,Skin exfoliation,16340977
3,2,22.0,Rash,16340977
4,2,22.0,Fatigue,16340977
5,2,22.0,Feeding disorder,16340977
0,6,22.0,Cholangitis,16341034
1,6,22.0,Device related infection,16341034
2,6,22.0,Rash,16341034
0,6,22.1,Bronchitis chronic,16341167
1,6,22.1,Haematotoxicity,16341167
2,6,22.1,Pericardial effusion,16341167
3,6,22.1,Central nervous system infection,16341167
4,6,22.1,Emphysema,16341167
0,6,22.0,Gastrointestinal disorder,16341174
1,2,22.0,Fat necrosis,16341174
2,6,22.0,Bone marrow failure,16341174
0,6,22.0,Pancreatitis,16341202
1,1,22.0,Gallbladder disorder,16341202
0,1,22.0,Ventricular extrasystoles,16341210
0,6,22.0,Bone marrow failure,16341249
1,1,22.0,Intestinal obstruction,16341249
2,2,22.0,Pulmonary embolism,16341249
0,6,22.0,Bone marrow failure,16341251
1,6,22.0,Neutropenia,16341251
0,1,22.0,Abdominal pain upper,16341252
0,1,22.0,Intestinal obstruction,16341291
0,1,22.1,Performance status decreased,16341294
1,1,22.1,Drug tolerance,16341294
2,6,22.1,Dermatomyositis,16341294
3,6,22.1,Neoplasm progression,16341294
4,6,22.1,Polymyositis,16341294
0,1,22.0,Rectal haemorrhage,16341307
1,1,22.0,Pleural effusion,16341307
2,6,22.0,Pleural effusion,16341307
3,1,22.0,Dyspnoea at rest,16341307
4,6,22.0,Dyspnoea,16341307
0,5,22.0,Benign neoplasm of adrenal gland,16341325
1,5,22.0,Prostate cancer metastatic,16341325
2,5,22.0,Drug ineffective,16341325
0,6,22.0,Gastrointestinal perforation,16341374
1,1,22.0,Radiation pneumonitis,16341374
0,1,22.0,Urinary tract infection,16341388
1,1,22.0,Pleural effusion,16341388
2,1,22.0,Pyrexia,16341388
0,3,22.0,Skin disorder,16341415
1,1,22.0,Interstitial lung disease,16341415
0,1,22.0,Syncope,16341447
0,6,22.0,Leukopenia,16341567
0,6,22.0,Pericardial effusion,16341584
1,6,22.0,Headache,16341584
2,6,22.0,Body temperature abnormal,16341584
3,6,22.0,Hepatic enzyme abnormal,16341584
4,6,22.0,Nausea,16341584
0,2,22.0,Nausea,16341637
1,2,22.0,Bone marrow failure,16341637
2,2,22.0,Diarrhoea,16341637
3,2,22.0,Cystitis,16341637
4,2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16341637
5,6,22.0,Intestinal obstruction,16341637
6,2,22.0,Gastroenteritis radiation,16341637
7,2,22.0,Vomiting,16341637
0,1,22.0,Atrioventricular block complete,16341718
0,5,22.0,Death,16341722
0,6,22.0,Depressed level of consciousness,16341733
1,6,22.0,Hypersomnia,16341733
2,6,22.0,Slow speech,16341733
0,6,22.0,Thyroid disorder,16341742
1,6,22.0,Hepatic lesion,16341742
2,6,22.0,Carbohydrate antigen 125 increased,16341742
0,1,22.0,Swollen tongue,16341784
1,1,22.0,Lip swelling,16341784
2,1,22.0,Erythema,16341784
3,1,22.0,Paraesthesia,16341784
0,6,22.0,Thrombosis,16341805
0,3,22.0,Arthritis,16341815
0,1,22.0,Bronchial disorder,16341825
0,5,22.0,Death,16341875
0,1,22.0,Back pain,16341886
1,1,22.0,Neutropenia,16341886
0,5,22.0,Death,16341919
1,3,22.0,Fatigue,16341919
2,3,22.0,Infection,16341919
3,3,22.0,Pyrexia,16341919
4,3,22.0,Decreased appetite,16341919
5,6,22.0,Product dose omission,16341919
6,3,22.0,Swelling,16341919
7,3,22.0,Dry mouth,16341919
0,1,22.0,Hypertension,16341963
1,6,22.0,Mucosal inflammation,16341963
2,6,22.0,Leukopenia,16341963
3,1,22.0,Weight decreased,16341963
4,6,22.0,Disease progression,16341963
5,6,22.0,Dyspepsia,16341963
6,6,22.0,Skin toxicity,16341963
7,6,22.0,Neutropenia,16341963
8,3,22.0,Neuropathy peripheral,16341963
9,1,22.0,Peritonsillar abscess,16341963
10,6,22.0,Diarrhoea,16341963
11,6,22.0,Gastrointestinal toxicity,16341963
12,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16341963
0,6,22.0,Adverse event,16341970
0,1,22.1,Pneumonitis,16342004
0,,22.0,Ovarian cancer recurrent,16342040
0,3,22.0,Arthralgia,16342054
1,3,22.0,Pain in extremity,16342054
0,1,22.0,Hypersensitivity,16342070
1,1,22.0,Seizure,16342070
2,1,22.0,Coma,16342070
0,6,22.0,Drug intolerance,16342086
0,6,22.0,Circumstance or information capable of leading to medication error,16342146
1,6,22.0,Product dose omission,16342146
2,6,22.0,Product availability issue,16342146
0,2,22.0,Blood magnesium decreased,16342148
0,5,22.0,Death,16342214
0,6,22.0,Anxiety,16342227
1,6,22.0,Decreased appetite,16342227
2,6,22.0,Fatigue,16342227
3,6,22.0,Insomnia,16342227
4,6,22.0,Rash,16342227
5,3,22.0,Gastric ulcer,16342227
6,3,22.0,Asthenia,16342227
7,6,22.0,Product use in unapproved indication,16342227
8,3,22.0,Pain,16342227
9,6,22.0,Malaise,16342227
10,1,22.0,Dysphagia,16342227
11,6,22.0,Red blood cell count decreased,16342227
12,6,22.0,Product use issue,16342227
13,6,22.0,Memory impairment,16342227
14,6,22.0,Weight decreased,16342227
15,6,22.0,Depression,16342227
16,1,22.0,Eating disorder,16342227
17,6,22.0,Back pain,16342227
18,3,22.0,Constipation,16342227
19,2,22.0,Nausea,16342227
20,6,22.0,Product use complaint,16342227
21,6,22.0,Headache,16342227
0,6,22.0,Seizure,16342265
0,6,22.0,Infection,16342269
0,,22.0,Death,16342272
0,1,22.0,Pneumothorax,16342408
0,5,22.0,Death,16342454
1,3,22.0,Cerebrovascular accident,16342454
0,3,22.0,Cancer pain,16342459
1,1,22.0,Eosinophil count increased,16342459
2,5,22.0,Bile duct cancer,16342459
3,5,22.0,Cholangitis,16342459
4,3,22.0,Gastric ulcer,16342459
0,3,22.0,Ejection fraction decreased,16342468
0,5,22.0,Death,16342494
0,6,22.0,Metastases to lung,16342499
1,6,22.0,Malignant neoplasm progression,16342499
0,1,22.0,Failure to thrive,16342501
1,1,22.0,Electrolyte imbalance,16342501
0,,22.0,Hormone-refractory prostate cancer,16342596
0,1,22.0,Thrombocytopenic purpura,16342609
0,2,22.0,Prostatic specific antigen increased,16342610
1,2,22.0,Disseminated intravascular coagulation,16342610
0,1,22.0,Rash,16342612
0,5,22.0,Death,16342630
0,1,22.0,Thrombosis,16342633
0,5,22.0,Death,16342641
0,2,22.0,Liver disorder,16342642
0,6,22.0,Idiopathic interstitial pneumonia,16342662
0,3,22.1,White blood cell count decreased,16342677
1,3,22.1,Rash,16342677
2,2,22.1,Neuropathy peripheral,16342677
3,3,22.1,Full blood count decreased,16342677
4,6,22.1,Product dose omission,16342677
0,6,22.0,Skin ulcer,16342687
0,5,22.0,Death,16342691
0,1,22.1,Neutrophil count decreased,16342700
1,6,22.1,Platelet count decreased,16342700
2,1,22.1,Atrioventricular block complete,16342700
0,2,22.0,Cholangitis,16342706
1,6,22.0,Malignant neoplasm progression,16342706
0,3,22.0,Myocarditis,16342765
0,5,22.1,Sepsis,16342804
1,1,22.1,Diarrhoea,16342804
2,1,22.1,Anaemia,16342804
3,1,22.1,Ileus,16342804
0,1,22.0,Pyrexia,16342805
0,6,22.0,Heart rate decreased,16342835
1,6,22.0,Cardiac pacemaker insertion,16342835
2,6,22.0,Fatigue,16342835
0,,22.0,Depressed level of consciousness,16342860
1,,22.0,Peritonitis,16342860
2,,22.0,Nausea,16342860
3,,22.0,Jejunal perforation,16342860
4,,22.0,Lethargy,16342860
5,,22.0,Speech disorder,16342860
6,,22.0,Mental status changes,16342860
7,,22.0,Sepsis,16342860
8,,22.0,Vomiting,16342860
9,,22.0,Small intestinal obstruction,16342860
0,3,22.0,Asthenia,16342870
1,6,22.0,Underdose,16342870
2,6,22.0,Fatigue,16342870
3,3,22.0,Cardiac flutter,16342870
4,6,22.0,Disease progression,16342870
5,3,22.0,Dizziness,16342870
6,3,22.0,Heart rate irregular,16342870
7,6,22.0,Carbohydrate antigen 125 increased,16342870
8,6,22.0,Blood pressure increased,16342870
9,1,22.0,Nausea,16342870
10,6,22.0,Headache,16342870
11,6,22.0,Recurrent cancer,16342870
12,6,22.0,Cough,16342870
13,6,22.0,Renal impairment,16342870
14,6,22.0,Malaise,16342870
0,1,22.0,Intestinal obstruction,16342891
0,6,22.0,Pulmonary oedema,16342892
0,6,22.0,Fracture,16342906
0,6,22.0,Fall,16342947
1,1,22.0,Femoral neck fracture,16342947
0,3,22.1,Platelet count decreased,16342956
1,1,22.1,White blood cell count decreased,16342956
2,6,22.1,Dyspnoea,16342956
3,3,22.1,Fatigue,16342956
4,3,22.1,Alopecia,16342956
5,3,22.1,Red blood cell count decreased,16342956
0,1,22.0,Chest discomfort,16342964
1,1,22.0,Erythema,16342964
2,1,22.0,Hypersensitivity,16342964
3,1,22.0,Back pain,16342964
0,6,22.0,Cholelithiasis,16342975
0,6,22.1,Cold sweat,16342986
1,5,22.1,Death,16342986
2,2,22.1,Penile haemorrhage,16342986
3,2,22.1,Haematuria,16342986
4,3,22.1,Hyperhidrosis,16342986
5,3,22.1,Back pain,16342986
6,3,22.1,Bone pain,16342986
7,2,22.1,Pyrexia,16342986
8,2,22.1,Vomiting,16342986
9,3,22.1,General physical health deterioration,16342986
10,3,22.1,Feeling hot,16342986
11,3,22.1,Coccydynia,16342986
0,3,22.0,Hypotension,16342997
1,3,22.0,Bradycardia,16342997
2,3,22.0,Haemoglobin decreased,16342997
3,3,22.0,Bedridden,16342997
4,3,22.0,Tachycardia,16342997
5,3,22.0,Prostate cancer,16342997
6,3,22.0,Dysuria,16342997
7,3,22.0,Dysphagia,16342997
8,3,22.0,Product use complaint,16342997
9,3,22.0,Hypotension,16342997
10,3,22.0,Oxygen saturation decreased,16342997
11,3,22.0,Respiratory distress,16342997
12,3,22.0,Blood urea increased,16342997
0,3,22.0,Mobility decreased,16343000
1,3,22.0,Prostatic specific antigen increased,16343000
2,3,22.0,Muscular weakness,16343000
0,6,22.1,Diarrhoea,16343036
1,6,22.1,Malignant neoplasm progression,16343036
2,6,22.1,Ileus,16343036
3,1,22.1,Renal impairment,16343036
4,6,22.1,Febrile neutropenia,16343036
5,3,22.1,Ovarian cancer recurrent,16343036
6,6,22.1,Platelet count decreased,16343036
0,,22.0,Asocial behaviour,16343039
1,,22.0,Alopecia,16343039
2,,22.0,Self esteem decreased,16343039
3,,22.0,Depression,16343039
4,,22.0,Crying,16343039
0,,22.0,Drug-induced liver injury,16343062
1,,22.0,Hepatic necrosis,16343062
2,,22.0,Liver injury,16343062
0,6,22.0,Type 2 diabetes mellitus,16343071
1,6,22.0,Cardiac disorder,16343071
2,6,22.0,Hypertension,16343071
3,6,22.0,Gastrooesophageal reflux disease,16343071
4,6,22.0,Hyperlipidaemia,16343071
5,6,22.0,Gout,16343071
6,6,22.0,Chronic obstructive pulmonary disease,16343071
0,6,22.0,Pleural effusion,16343076
1,4,22.0,Dyspnoea,16343076
2,6,22.0,Breast cancer,16343076
3,6,22.0,Malignant neoplasm progression,16343076
0,6,22.0,Abdominal pain,16343080
1,6,22.0,Vomiting,16343080
2,4,22.0,Urinary tract infection,16343080
3,6,22.0,Nausea,16343080
4,6,22.0,Calculus bladder,16343080
5,6,22.0,Diarrhoea,16343080
6,6,22.0,Clostridium difficile infection,16343080
0,,22.0,Pain,16343101
1,,22.0,Hypoaesthesia,16343101
2,,22.0,Fatigue,16343101
0,6,22.0,Prostatic specific antigen abnormal,16343120
1,6,22.0,Inappropriate schedule of product administration,16343120
2,6,22.0,Chest pain,16343120
3,6,22.0,Abdominal discomfort,16343120
4,6,22.0,Nausea,16343120
5,6,22.0,Musculoskeletal pain,16343120
6,6,22.0,Abdominal pain,16343120
7,1,22.0,Rash pruritic,16343120
8,6,22.0,Bone pain,16343120
9,6,22.0,Constipation,16343120
10,6,22.0,Pain in extremity,16343120
11,6,22.0,Diarrhoea,16343120
12,6,22.0,Somnolence,16343120
13,6,22.0,Lethargy,16343120
0,6,22.0,Blood alkaline phosphatase increased,16343132
1,6,22.0,Hepatic function abnormal,16343132
2,6,22.0,Neutrophil count decreased,16343132
0,1,22.0,Gastrointestinal haemorrhage,16343138
1,2,22.0,Prostatic specific antigen increased,16343138
0,1,22.0,Sense of oppression,16343142
1,1,22.0,Pulmonary embolism,16343142
0,3,22.1,Pancreatitis acute,16343150
0,,22.0,Peripheral swelling,16343273
1,,22.0,Therapy cessation,16343273
2,,22.0,Lung infection,16343273
0,6,22.0,Herpes zoster,16343327
0,1,22.0,Administration site urticaria,16343328
1,1,22.0,Hypoaesthesia,16343328
2,3,22.0,Administration site necrosis,16343328
0,1,22.1,Liver disorder,16343379
1,5,22.1,Malignant neoplasm progression,16343379
2,6,22.1,Metastases to central nervous system,16343379
3,1,22.1,Jaundice cholestatic,16343379
0,,22.0,Hepatic cancer,16343391
1,,22.0,Fatigue,16343391
2,,22.0,Stomatitis,16343391
3,,22.0,Decreased appetite,16343391
0,1,22.0,Respiratory distress,16343431
